CXCL1 and Cognitive impairment: In contrast, an identical VX-765 treatment regimen and Casp1 KO in 5- to 8-month-old J20 normalized Iba1+-microglia, elevated hippocampal TNF-α and CXCL1, and reversed or prevented the onset of cognitive impairment [11, 12].